19 June 2013
Keywords: merck, kgaa, seeks, eu, ok, erbitux, mcrc
Article | 10 September 2007
German drugmaker Merck KGaA has submitted a supplemental Marketing Authorization Application to the European Medicines Agency (EMEA),
seeking approval for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 September 2007
17 September 2007
18 June 2013
© 2013 thepharmaletter.com